Agilent to Support Lipidomics Research Consortium Led by National University of Singapore - - Chromatography Online
Agilent to Support Lipidomics Research Consortium Led by National University of Singapore

LCGC Europe eNews

The National University of Singapore (Singapore) is leading a research consortium to develop the world’s first lipid database for different racial and ethnic groups, supported by Agilent Technologies (California, USA). When completed, the project will provide a centralized resource for researchers studying fat levels as diagnostic markers.

The NUS Singapore Lipidomics Incubator (SLING) founded the Lipidomic Natural Variation (L–NAVA) consortium together with other founding members including South Korea's Graduate School of Analytical Science and Technology (GRAST) at Chungnam National University; Baker IDI Heart and Diabetes Institute (Melbourne, Australia); and Agilent Technologies. The members will use liquid chromatography–mass spectrometry instrumentation from Agilent for the project.

Markus Wenk, director of SLING, said: "Understanding natural variations is a major aim of SLING. This network allows us to extend, and hopefully connect, our studies on lipids with others that address variability at the level of genes, proteins, and sugars. Doing this in healthy individuals will provide a broad, foundational basis relevant for a better understanding of onset of diseases."

Rod Minett, Agilent's general manager, Life Sciences, South Korea and the South Asia-Pacific region, said: "We are honoured to be part of this new consortium, supporting its goal to systematically determine lipid profiles across different groups of humans." He added: "Agilent's innovations in bio-analytical instruments will help consortium members in their research on the natural variations using different methods. We hope this resource will help medical professionals provide better-quality care to their patients."

For more information visit: or


blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:



Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration

Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies

MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis

LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase

More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>

Source: LCGC Europe eNews,
Click here